Significantly, PTEN loss is highly associated with BRCA1-defective breast cancers, probably due to genomic instability resulting from deficient DSB repair [68], and the resulting PI3K/AKT activation stimulates the growth of those cancers [69]. Here, AKT1 is linked to cancer.